191 related articles for article (PubMed ID: 19423011)
21. Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity.
Yamada K; Brink I; Bissé E; Epting T; Engelhardt R
J Dermatol; 2005 May; 32(5):316-34. PubMed ID: 16043894
[TBL] [Abstract][Full Text] [Related]
22. The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
Lea S; Plumb J; Metcalfe H; Spicer D; Woodman P; Fox JC; Singh D
Eur Respir J; 2014 Feb; 43(2):409-20. PubMed ID: 23794466
[TBL] [Abstract][Full Text] [Related]
23. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.
Nugent C; Prins JB; Whitehead JP; Savage D; Wentworth JM; Chatterjee VK; O'Rahilly S
Mol Endocrinol; 2001 Oct; 15(10):1729-38. PubMed ID: 11579205
[TBL] [Abstract][Full Text] [Related]
24. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
[TBL] [Abstract][Full Text] [Related]
25. A phase II clinical trial to investigate the effect of pioglitazone on (18)F-FDG uptake in malignant lesions.
Han YH; Kwon SY; Kim J; Na CJ; Choi S; Min JJ; Bom HS; Kim YC; Oh IJ; Chae HJ; Lim ST; Sohn MH; Jeong HJ
EJNMMI Res; 2015 Dec; 5(1):50. PubMed ID: 26408008
[TBL] [Abstract][Full Text] [Related]
26. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Aloj L; Caracó C; Jagoda E; Eckelman WC; Neumann RD
Cancer Res; 1999 Sep; 59(18):4709-14. PubMed ID: 10493529
[TBL] [Abstract][Full Text] [Related]
27. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
Liu D; Zeng BX; Zhang SH; Yao SL
Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?
Mees G; Dierckx R; Vangestel C; Laukens D; Van Damme N; Van de Wiele C
Mol Imaging; 2013; 12(1):49-58. PubMed ID: 23348791
[TBL] [Abstract][Full Text] [Related]
29. Changes in 2-fluoro-2-deoxy-D-glucose incorporation, hexokinase activity and lactate production by breast cancer cells responding to treatment with the anti-HER-2 antibody trastuzumab.
Cheyne RW; Trembleau L; McLaughlin A; Smith TA
Nucl Med Biol; 2011 Apr; 38(3):339-46. PubMed ID: 21492782
[TBL] [Abstract][Full Text] [Related]
30.
Rodrigues RS; Bozza FA; Hanrahan CJ; Wang LM; Wu Q; Hoffman JM; Zimmerman GA; Morton KA
Nucl Med Biol; 2017 May; 48():52-62. PubMed ID: 28237630
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography.
Folco EJ; Sheikine Y; Rocha VZ; Christen T; Shvartz E; Sukhova GK; Di Carli MF; Libby P
J Am Coll Cardiol; 2011 Aug; 58(6):603-14. PubMed ID: 21798423
[TBL] [Abstract][Full Text] [Related]
32. Molecular imaging of murine intestinal inflammation with 2-deoxy-2-[18F]fluoro-D-glucose and positron emission tomography.
Brewer S; McPherson M; Fujiwara D; Turovskaya O; Ziring D; Chen L; Takedatsu H; Targan SR; Wei B; Braun J
Gastroenterology; 2008 Sep; 135(3):744-55. PubMed ID: 18639553
[TBL] [Abstract][Full Text] [Related]
33. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
Park SG; Lee JH; Lee WA; Han KM
Nucl Med Biol; 2012 Nov; 39(8):1167-72. PubMed ID: 22901702
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
Duan SZ; Usher MG; Mortensen RM
Circ Res; 2008 Feb; 102(3):283-94. PubMed ID: 18276926
[TBL] [Abstract][Full Text] [Related]
35. Quantification of PPAR-gamma protein in monocyte/macrophages from healthy smokers and non-smokers: a possible direct effect of nicotine.
Amoruso A; Bardelli C; Gunella G; Fresu LG; Ferrero V; Brunelleschi S
Life Sci; 2007 Aug; 81(11):906-15. PubMed ID: 17765929
[TBL] [Abstract][Full Text] [Related]
36. Differential ability of a thiazolidinedione PPARgamma agonist to attenuate cytokine secretion in primary microglia and macrophage-like cells.
Woster AP; Combs CK
J Neurochem; 2007 Oct; 103(1):67-76. PubMed ID: 17573821
[TBL] [Abstract][Full Text] [Related]
37. Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge.
Liu Y; Shi J; Lu J; Meng G; Zhu H; Hou Y; Yin Y; Zhao S; Ding B
Innate Immun; 2009 Jun; 15(3):169-78. PubMed ID: 19474210
[TBL] [Abstract][Full Text] [Related]
38. Experimental study on the therapeutic effect of positron emission tomography agent [¹⁸F]-labeled 2-deoxy-2-fluoro-d-glucose in a colon cancer mouse model.
Fang S; Wang J; Jiang H; Zhang Y; Xi W; Zhao C; Tian M; Zhang H
Cancer Biother Radiopharm; 2010 Dec; 25(6):733-40. PubMed ID: 21204768
[TBL] [Abstract][Full Text] [Related]
39. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ
Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
